Hareesh B. Nair

Also affiliated with The University of Texas at San Antonio Health Science Center, Evestra (United States), The University of Texas Health Science Center at Houston, Texas Tech University Health Sciences Center

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Targeting LIF/LIFR signaling in cancer”.

Targeting LIF/LIFR signaling in cancer

Genes & Diseases(2021)10.1016/j.gendis.2021.04.003

N/A

0DataRank · unranked

112 citations

K.V. Dileep, Kam Y. J. Zhang, Hareesh B. Nair, Ratna K. Vadlamudi, Suryavathi Viswanadhapalli

LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancer

Communications Biology(2021)10.1038/s42003-021-02741-7

N/A

0DataRank · unranked

23 citations

Suryavathi Viswanadhapalli, Bindu Santhamma, Uday P. Pratap, Yiliao Luo, Junhao Liu +21 more

The Pleiotropic role, functions and targeted therapies of LIF/LIFR axis in cancer: Old spectacles with new insights

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer(2022)10.1016/j.bbcan.2022.188737

N/A

0DataRank · unranked

33 citations

Seema Parte, Prakash Kshirsagar, Sakthivel Muniyan, Hareesh B. Nair, Surinder K. Batra +2 more

Pharmacological inhibition of the LIF/LIFR autocrine loop reveals vulnerability of ovarian cancer cells to ferroptosis

npj Precision Oncology(2024)10.1038/s41698-024-00612-y

N/A

0DataRank · unranked

20 citations

Suryavathi Viswanadhapalli, Uday P. Pratap, Gopalam Rahul, Xue Yang, Prabhakar Pitta Venkata +19 more

Significance of LIF/LIFR Signaling in the Progression of Obesity-Driven Triple-Negative Breast Cancer

Cancers(2024)10.3390/cancers16213630

N/A

0DataRank · unranked

4 citations

Jaitri Joshi, Alondra L. Rodriguez Sanchez, Uday P. Pratap, Rahul Gopalam, Yidong Chen +8 more

Targeting cancer-associated fibroblast-driven LIF/LIFR axis improves the therapeutic efficacy of gemcitabine and nab-paclitaxel in pancreatic cancer

npj Precision Oncology(2025)10.1038/s41698-025-01046-w

N/A

0DataRank · unranked

9 citations

Imran Khan, Xiaoqi Li, Shailendra K. Gautam, Parthasarathy Seshacharyulu, Zahraa Wajih Alsafwani +10 more

EC359 Enhances Trametinib Efficacy in Ras/Raf-Driven Ovarian Cancer by Suppressing LIFR Signaling

Biomolecules(2025)10.3390/biom15101396

N/A

0DataRank · unranked

0 citations

Durga Meenakshi Panneerdoss, Baskaran Subramani, Megharani Mahajan, Behnam Ebrahimi, Paulina Ramirez +9 more